新生儿基因筛查对早期识别GJB2和SLC26A4相关听力损失的重要性
该回顾性队列研究纳入2015年1月至2018年2月在加拿大三级儿童医院经下一代测序(NGS)确诊的485例听力损失儿童,比较新生儿听力筛查与安大略省扩展新生儿基因筛查对GJB2和SLC26A4相关听力损失的识别效果。结果显示基因筛查与听力筛查联合可改善早期识别,对GJB2相关听力损失尤为明显。
要点
- NGS识别出35例GJB2或SLC26A4相关听力损失儿童,其中听力筛查识别20例(57%)。
- 20例中仅10例(50%)可被现有扩展基因筛查识别,GJB2组为9/14(64%),SLC26A4组为1/6(17%)。
- 8例听力筛查通过但后来出现听力损失者中,3例(38%)可被基因筛查识别,均为GJB2组(3/6)。
核心结论
- 安大略省扩展新生儿听力筛查项目中的基因筛查与听力筛查联合可改善听力损失儿童的早期识别,包括那些仅靠听力筛查可能被漏诊的儿童,对GJB2相关听力损失最为明显。
研究设计与样本
- 回顾性队列研究,从2015年1月至2018年2月在加拿大三级儿童医院接受下一代测序(NGS)检测的485例听力损失儿童中,识别出已知GJB2和SLC26A4变异的儿童。
主要发现
- NGS共识别35例GJB2和SLC26A4相关听力损失儿童(GJB2相关27例,SLC26A4相关8例)。
- 其中20例(57%)被新生儿听力筛查识别(GJB2相关14/27,52%;SLC26A4相关6/8,75%)。
- 20例中10例(50%)在基因筛查可用时也可被识别(GJB2相关9/14,64%;SLC26A4相关1/6,17%)。
- 另有8例GJB2或SLC26A4相关听力损失儿童通过新生儿听力筛查但后来出现听力损失,其中3例(38%)可被新生儿基因筛查识别(GJB2相关3/6;SLC26A4相关0/2)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the added benefit of newborn genetic screening for GJB2 and SLC26A4 variants in conjunction with newborn hearing screening. STUDY DESIGN: Retrospective cohort study. METHODS: Children with known variants of GJB2 and SLC26A4 were identified from 485 children with hearing loss who underwent testing with Next Generation Sequencing (NGS) between January 2015 and February 2018, prior to expanded screening for genetic variants and congenital CMV. Children with two pathogenic or likely pathogenic variants of GJB2 or SLC26A4 were considered to have genetic hearing loss. NGS genetic data were compared to variants included in the expanded genetic screen for all newborns in Ontario and newborn hearing screening results. SETTING: Canadian tertiary pediatric hospital. RESULTS: Thirty-five children with GJB2 and SLC26A4-associated hearing loss were identified by NGS (n = 27 GJB2-HL; n = 8 SLC26A4-HL). Of these, 20 (57%) had been identified by newborn hearing screening (14/27 52% GJB2-HL; 6/8 75% SLC26A4-HL). Ten of the 20 (50%) would also have been identified by genetic screening if it had been available (9/14 64% GJB2-HL; 1/6 17% SLC26A4-HL). An additional 8 children with GJB2 or SLC26A4-associated hearing loss passed their newborn hearing screen but showed hearing loss later; three of these children (38%) would have been identified by newborn genetic screening (3/6 GJB2-HL; 0/2 SLC26A4-HL). CONCLUSION: Genetic and hearing screening modalities in Ontario's expanded newborn hearing screening program improve early identification of children with hearing loss including those at risk of being missed by hearing screening alone. This was most clear for children with GJB2-hearing loss.
引用
- Wener ER, Cushing SL, Papsin BC, et al. The Importance of Newborn Genetic Screening for Early Identification of GJB2 and SLC26A4 Related Hearing Loss. Otolaryngol Head Neck Surg. 2025. PMID: 40008839. doi:10.1002/ohn.1188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。